Free Trial

Helius Medical Technologies Q3 2023 Earnings Report

Helius Medical Technologies logo
$0.91 +0.43 (+89.58%)
(As of 12/20/2024 05:45 PM ET)

Helius Medical Technologies EPS Results

Actual EPS
-$5.49
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Helius Medical Technologies Revenue Results

Actual Revenue
$0.14 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Helius Medical Technologies Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

Collect $7k per month from Tesla’s SECRET dividend (Ad)

Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69% dividend from Tesla… Which could put up to $7,013 in your pocket every month…

Click here to discover the new #1 way to invest in Tesla

Helius Medical Technologies Earnings Headlines

$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.
Helius Medical Technologies (HSDT) Gets a Hold from Maxim Group
See More Helius Medical Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Helius Medical Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Helius Medical Technologies and other key companies, straight to your email.

About Helius Medical Technologies

Helius Medical Technologies (NASDAQ:HSDT), a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.

View Helius Medical Technologies Profile

More Earnings Resources from MarketBeat

Upcoming Earnings